Molecules of Korolchuk IP-NFT VITA-FAST Social Audit & Trust Score

VITA-FAST: Empowering Longevity Research through Decentralized Governance

In a groundbreaking initiative, VitaDAO, a decentralized autonomous organization, is spearheading a unique funding model for longevity research. Their VITA-FAST project introduces ERC-20 tokens, representing fractional ownership of Intellectual Property Non-Fungible Tokens (IP-NFT) resulting from the innovative work conducted at the Korolchuk Lab, Newcastle University.

The Quest for Autophagy Activation

At the heart of the project is a focused mission: to discover and develop therapeutic compounds capable of reactivating autophagy in Npc1 -/- cells. This crucial endeavor involves screening a myriad of bioactive and commercial small molecules in cell survival assays, seeking potential autophagy activators that are non-cytotoxic. The project employs cutting-edge techniques like luciferase-p6 clearance and Halo-GFP-LC3 orthogonal assays to identify compounds with high chemical variability and no resemblance to existing autophagy inducers.

Uniqueness in Approach

What sets VITA-FAST apart is its commitment to identifying novel compounds for inducing autophagy in NPC1 -/- cells, a critical process in treating Niemann-Pick Type C disease. Unlike conventional treatments, this project utilizes high-throughput screening methods and innovative assays, offering possibilities for entirely new Intellectual Property (IP) creation.

Evolution and Progress

Led by Dr. Korolchuk and his team, the project has evolved from generating data on thousands of compounds to identifying lead compounds with potential autophagic properties. The journey encompasses the synthesis of derivatives and is now advancing towards drug translation processes, including pharmacokinetics and scalability studies.

Future Endeavors

Looking ahead, the project is set to embark on screening third-generation compounds, employing in vitro and in vivo models with a focus on patient-centric approaches.

VITA-FAST Tokens: A Gateway to Participation

The VITA-FAST tokens open doors for enthusiasts and supporters to directly engage with the pioneering work of the Korolchuk Lab. By holding these tokens, individuals gain governance rights over the Intellectual Property, democratizing decision-making processes in scientific research and contributing to the advancement of autophagy research.

Founding Vision

Founded in 2021 by Tyler Golato, VitaDAO is driven by a visionary commitment to revolutionize longevity research. Golato's approach involves community-driven decision-making and decentralized funding, showcasing a belief in the power of collective action to drive transformative change.

In conclusion, VITA-FAST stands at the intersection of cutting-edge science, decentralized governance and community involvement. As the project continues its quest for innovative compounds to activate autophagy, it beckons a future where groundbreaking discoveries in longevity research are not just observed but actively shaped by a community of engaged stakeholders.

What is unique about Molecules of Korolchuk IP-NFT (VITA-FAST)?

VITA-FAST stands out for its innovative approach in discovering compounds to reactivate autophagy in NPC1 -/- cells, addressing Niemann-Pick Type C disease. The project utilizes high-throughput screening and cutting-edge assays, aiming to create novel Intellectual Property with chemical variability distinct from existing autophagy inducers.

Who are the founders of Molecules of Korolchuk IP-NFT (VITA-FAST)?

VITA-FAST was founded in 2021 by Tyler Golato, a visionary leader committed to revolutionizing longevity research through community-driven decision-making and decentralized funding.

Where can I buy Molecules of Korolchuk IP-NFT (VITA-FAST)?

You can buy Molecules of Korolchuk IP-NFT (VITA-FAST) on Uniswap V3 (Ethereum) cryptocurrency exchanges.

Information in this section carefully collected and curated from publicly available data from official sources, including the Molecules of Korolchuk IP-NFT Official Website.

The information presented on this page is created and published by the OGAudit Editorial Team for educational and informational purposes. It should NOT be construed as an endorsement, or as legal, or investment advice. If you believe any content on this page is outdated or incorrect, please feel free to contact us for updates and corrections.